Who’s Hired? Endo Names New CEO

While Mylan and Pfizer’s Viatris Builds Its Leadership Team

Endo has named a new CEO and CFO, while Mylan and Pfizer’s Viatris has found its CFO and announced its full roster of board members. Meanwhile, Assogenerici names the leaders of its value added medicines sector group, law firm Fish & Richardson gets a new CEO and France appoints a new health minister.

HR_Management
Endo, Viatris and Siegfried get new board members • Source: Shutterstock

More from Leadership

More from Generics Bulletin